DK0657411T3 - Forbedret syntese af bisindolylmaleimider - Google Patents

Forbedret syntese af bisindolylmaleimider

Info

Publication number
DK0657411T3
DK0657411T3 DK94308948T DK94308948T DK0657411T3 DK 0657411 T3 DK0657411 T3 DK 0657411T3 DK 94308948 T DK94308948 T DK 94308948T DK 94308948 T DK94308948 T DK 94308948T DK 0657411 T3 DK0657411 T3 DK 0657411T3
Authority
DK
Denmark
Prior art keywords
bisindolylmaleimides
improved synthesis
synthesis
compounds
stereoselective
Prior art date
Application number
DK94308948T
Other languages
English (en)
Inventor
Margaret Mary Faul
Jr William Francis Heath
Michael Robert Jirousek
Iii John Hampton Mcdonald
Christopher John Rito
Jr Leonard Larry Winneroski
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/317,140 external-priority patent/US5541347A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0657411T3 publication Critical patent/DK0657411T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C07C43/1745—Unsaturated ethers containing halogen containing six-membered aromatic rings having more than one ether bound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1785—Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
DK94308948T 1993-12-07 1994-12-02 Forbedret syntese af bisindolylmaleimider DK0657411T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16306093A 1993-12-07 1993-12-07
US08/317,140 US5541347A (en) 1993-12-07 1994-10-03 Synthesis of bisindolylmaleimides

Publications (1)

Publication Number Publication Date
DK0657411T3 true DK0657411T3 (da) 1999-11-15

Family

ID=26859319

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94308948T DK0657411T3 (da) 1993-12-07 1994-12-02 Forbedret syntese af bisindolylmaleimider

Country Status (13)

Country Link
US (2) US5614647A (da)
EP (1) EP0657411B1 (da)
JP (1) JPH07238044A (da)
AT (1) ATE181049T1 (da)
BR (1) BR9404830A (da)
CA (1) CA2137205A1 (da)
DE (1) DE69418978T2 (da)
DK (1) DK0657411T3 (da)
ES (1) ES2134910T3 (da)
FI (1) FI945705A (da)
GR (1) GR3030722T3 (da)
HU (1) HUT69164A (da)
IL (1) IL111851A (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
BR9710648A (pt) * 1996-03-20 1999-08-17 Lilly Co Eli S¡ntese de indolilmaleimidas
CA2253608A1 (en) 1996-05-01 1997-11-06 Louis Vignati Therapeutic treatment for vegf related diseases
UA54427C2 (uk) * 1996-05-01 2003-03-17 Елі Ліллі Енд Компані Спосіб лікування очних захворювань, які пов'язані з фактором васкулярного ендотеліального росту
US6232299B1 (en) 1996-05-01 2001-05-15 Eli Lilly And Company Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
US6107327A (en) * 1996-08-30 2000-08-22 Eli Lilly And Company Therapeutic treatment for HIV infection
US5962446A (en) * 1996-08-30 1999-10-05 Eli Lilly And Company Therapetutic treatment for human T cell lymphotrophic virus type 1 infection
US5859261A (en) * 1997-03-20 1999-01-12 Eli Lilly And Company Synthesis of indolylmaleimides
US6093740A (en) * 1997-04-30 2000-07-25 Eli Lilly And Company Therapeutic treatment for skin disorders
JP3646651B2 (ja) * 1998-01-30 2005-05-11 ダイソー株式会社 ブタントリオール誘導体の製造法
US6103713A (en) * 1998-03-05 2000-08-15 Eli Lilly And Company Therapeutic treatment for autoimmune diseases
US6225301B1 (en) 1998-03-05 2001-05-01 Eli Lilly And Company Therapeutic treatment for renal dysfunction
US6103712A (en) * 1998-03-05 2000-08-15 Eli Lilly And Company Therapeutic treatment for asthma
US6291446B1 (en) 1998-03-05 2001-09-18 Eli Lilly And Company Therapeutic treatment for cytomegalovirus infection
EP2181999A1 (en) * 2008-11-03 2010-05-05 Zentiva, A.S. Method of manufacturing ruboxistarin
US11319320B2 (en) 2017-11-06 2022-05-03 Snap Bio, Inc. PIM kinase inhibitor compositions, methods, and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
WO1988007045A1 (en) * 1987-03-09 1988-09-22 Kyowa Hakko Kogyo Co., Ltd. Derivatives of physiologically active substance k-252
US5438050A (en) * 1988-02-06 1995-08-01 Godecke Aktiengesellschaft Indolocarbazole derivatives, processes for their preparation and compositions containing them
DE3803620A1 (de) * 1988-02-06 1989-08-17 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
CZ280738B6 (cs) * 1988-02-10 1996-04-17 F. Hoffmann - La Roche And Co., Aktiengesellschaft Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi
MC2096A1 (fr) * 1989-02-23 1991-02-15 Hoffmann La Roche Pyrroles substitues
DE3914764A1 (de) * 1989-05-05 1990-11-08 Goedecke Ag Maleinimid-derivate und deren verwendung als arzneimittel
CA2015996C (en) * 1989-05-05 2001-08-28 Hartmut Osswald Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals
DE3942296A1 (de) * 1989-12-21 1991-06-27 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
DE4005970A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte maleinimide, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles
GB9123396D0 (en) * 1991-11-04 1991-12-18 Hoffmann La Roche A process for the manufacture of substituted maleimides
US5461146A (en) * 1992-07-24 1995-10-24 Cephalon, Inc. Selected protein kinase inhibitors for the treatment of neurological disorders
WO1994007895A1 (en) * 1992-09-25 1994-04-14 Schering Corporation Diindolo compounds and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ES2134910T3 (es) 1999-10-16
IL111851A (en) 1998-09-24
US5614647A (en) 1997-03-25
FI945705A0 (fi) 1994-12-02
FI945705A (fi) 1996-06-03
BR9404830A (pt) 1995-08-08
US5665877A (en) 1997-09-09
GR3030722T3 (en) 1999-11-30
HU9403467D0 (en) 1995-02-28
JPH07238044A (ja) 1995-09-12
CA2137205A1 (en) 1995-06-08
EP0657411A1 (en) 1995-06-14
DE69418978T2 (de) 1999-10-28
HUT69164A (en) 1995-08-28
IL111851A0 (en) 1995-03-15
ATE181049T1 (de) 1999-06-15
EP0657411B1 (en) 1999-06-09
DE69418978D1 (de) 1999-07-15

Similar Documents

Publication Publication Date Title
DK0657411T3 (da) Forbedret syntese af bisindolylmaleimider
PT1312609E (pt) Compostos de acido e ester boronico, sinteses e utilizacoes
DK0789578T3 (da) Inhibitorer af multikatalytisk protease
FI933566A0 (fi) Nytt foerfarande foer framstaellning av 7-(substituerade)-9-((substituerad glycyl)amido)-6-demetyl-6-deoxitetracykliner
DK0446699T3 (da) Inhibitorer af nitrogenoxid-biosyntese
DK0617018T3 (da) Beta-Lactamer, fremgangsmåde til fremstilling af taxaner og sidekæde-bærende taxaner
DK0994108T3 (da) Fremgangsmåde til fremstilling af 2-hydroxybenzamidderivater
ATE263771T1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ATE199560T1 (de) Festphasensynthese von oligoribonucleotiden
DK0532515T3 (da) Fremstilling af substituerede piperidiner
EA200000094A1 (ru) Способ получения замещенного пергидроизоиндола
DE69109167D1 (de) Dicyanat Ester von Dihydroxyphenolen, bei niedriger Temperatur härtbar.
DK0782996T3 (da) Fremgangsmåde til fremstilling af N-biphenylmethylthiadiazolinderivat eller salt deraf og mellemprodukt til fremstilling af
DK1023292T3 (da) Fremgangsmåde til syntese af chlorpurinintermediater
ATE170862T1 (de) 5-ht3 pyrrolopyrazinderivate
DK0662961T3 (da) Fremgangsmåde til syntese af nyttige mellemprodukter af substituerede imidazolforbindelser
DK0425929T3 (da) Fremgangsmåde til fremstilling af mellemprodukter og til syntese af N-(2-hydroxyethyl)-2- hydroxymethyl-3,4,5-trihydroxypiperidiner
ES2120483T3 (es) Alcoholes benzilo y benzhidrilo.
FI962592A0 (fi) Uudet välituotteet keinotekoisina makeutusaineina käyttökelpoisten L-aspartyyli-D-alfa-aminoalkanoyyli-(S)-N-alfa-alkyylibentsyyliamidien syntetisoimiseksi
DK0809643T3 (da) Syntese af (+)-pancratistatin
DK0761657T3 (da) Fremgangsmåde til fremstilling af benzylsubstituerede rhodaninderivater
ATE135352T1 (de) 3-keto-hmg-coa reduktase-inhibitoren